RJF vs UPB · rev $15.91B vs rev $2.9M
RJF (RJF) versus Upstream Bio, Inc. (UPB) — a side-by-side from cached financials, not a winner call.
RJF (RJF) common stock.
Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
Latest reported UPB revenue for 2025-12-31 was $2.9M. Net income was -$143.4M. Revenue was up 20.4% from 2024-12-31 to 2025-12-31. UPB currently screens at market cap $407.3M.
RJF currently screens at market cap $0. UPB currently screens at market cap $407.3M.
Not investment advice. Open the RJF and UPB stock pages for the full models.
Not investment advice.